Skip to content

Pain Reprocessing Therapy for Chronic Primary Pain

Pain Reprocessing Therapy for Chronic Primary Pain Caused by a Likely Nociplastic Pain Mechanism in Primary Care: The PRIME-PRT Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07287072
Acronym
PRIME-PRT
Enrollment
12
Registered
2025-12-17
Start date
2026-02-01
Completion date
2026-12-31
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Primary Pain, Nociplastic Pain

Keywords

chronic primary pain, Nociplastic pain, Pain Reprocessing Therapy

Brief summary

Approximately 30% of adult Norwegians experience chronic pain, with its prevalence rising across demographics, including children and adolescents Chronic pain contributes to significant personal suffering and substantial societal costs. Traditional treatments - physical, pharmacological, and surgical - as well as psychological interventions, such as cognitive and acceptance-based therapies, demonstrate only minor to modest effects. To address the challenge of rising demand alongside limited treatment options, university hospitals must consistently evaluate and adopt new, potentially effective therapies to meet their societal mission. Pain Reprocessing Therapy (PRT) is one such innovative treatment that has recently demonstrated promising results for a subset of chronic pain patients in a U.S. primary care setting. In this study, the investigators want to assess the effectiveness of PRT on various outcomes in patients with primary chronic pain that has a likely nociplastic pain mechanism, within a Norwegian primary care population. The insights from this study will be important for any prospective implementation of PRT to align with one of the guiding principles of the Norwegian healthcare system: the Best Effective Level of Care (BEON principle). The BEON principle supports the delivery of high-quality, cost-effective healthcare services and is founded on the notion of seamless integration across different levels of care. When competence or resources at the primary healthcare level are insufficient, more patients tend to be referred to higher, specialized, and inherently more costly levels of care, such as secondary and tertiary care. Therefore, if the study can demonstrate that PRT is effective within a Norwegian primary care population, the hypothesize is that its implementation could strengthen both primary and tertiary care in alignment with the BEON principle.

Interventions

Pain Reprocessing Therapy (PRT) has shown promising results for patients with chronic primary back pain with a nociplastic pain-mechanism. PRT consists of two components. The first is an educational component (E) conducted by a physician. The purpose of the educational component is to reorient the patient's understanding of pain in accordance with the theories of nociplastic pain (false alarm based on negative expectations). The second part consists of a set of specific therapeutic techniques (T) that can be performed by a physician, psychologist, or other trained healthcare personnel. The techniques are easy to learn and have a training framework of 50 hours over a period of 3 months. They are based, among other things, on interoceptive exposure techniques, where the main point is to confront internal sensory experiences that have been interpreted as threatening (and ultimately lead to pain), with a new assurance that they do not signal danger ("false alarm").

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single Case Experimental Design (SCED). In a SCED study, the unit of analysis is the individual rather than the group, and the patient serves as their own control. Participants will be randomized to different starting periods for the intervention (Phase B) as soon as they are included in the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 70 * On sick leave, or at risk of sick leave * Pain intensity corresponding to 3 (or more) on the NRS from the PROMIS-29. * Readiness to change, corresponding to the action stage from the readiness to change model, where they are ready to participate in their own change process

Exclusion criteria

* Structural causes for their pain (rheumatoid arthritis, cancer, etc.), * Severe psychiatric conditions (ongoing or previous psychotic disorders, suicidality, or severe depression/anxiety/bipolar disorder) * Illegal substance abuse, or known dependence on benzodiazepines or opioids * Ongoing litigation or compensation process related to the pain condition * Ongoing and severe psychosocial stressors (e.g. recent divorce etc.)

Design outcomes

Primary

MeasureTime frameDescription
Average pain rating in the past 7 days on a numerical rating scale from 0-10 from Patient-Reported Outcomes Measurement Information System - 29 items (PROMIS-29)5-week post-treatment assessment (5 weeks after first PRT session; 1 week after final PRT session)Pain intensity average last week assessed through one item. The scale ranges from 0 (no pain) to 10 (worst imaginable pain)

Secondary

MeasureTime frameDescription
Physical function measured through PROMIS-295-week post-treatment assessment (5 weeks after first PRT session; 1 week after final PRT session), 3 monts and at 1 year follow-upPatient-Reported Outcome Measurement Information System (PROMIS-29) average score post-treatment on the domain Physical function. Scores range from 4-20, with higher scores indicating better function
Individual goals assessed through Goal Attainment Scaling (GAS)5-week post-treatment assessment (5 weeks after first PRT session; 1 week after final PRT session), 3 months and at 1 year follow-upIndividual goals as defined by the patient. For instance: "Running up a hill" or "playing basketball" (Ref to GAS: Ruble et al., 2012).
Work participation at 1-year follow-upAssessed through self-report at 5 weeks follow-up and 1 year follow-upIncreased work participation since baseline (y/n)
Patient Global Impression of Change5-week post-treatment assessment (5 weeks after first PRT session; 1 week after final PRT session)Patients' global impression of change in symptoms, function and quality of life (Hurst, 2004). The scale ranges from 1 (no change) to 7 (a great deal better and considerable improvement)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026